Jeffrey P. Callen MD, FACP, MAAD, MACR
Professor of Medicine (Dermatology) and Lafayette G. Owen Chair; Chief, Division of Dermatology, University of Louisville, Louisville, KentuckyJeffrey P. Callen, MD was born in Chicago, Il. He went to University of Wisconsin in Madison, Wisconsin (1965-8) and University of Michigan Medical School (1968-72). He completed residencies in internal medicine and dermatology at the University of Michigan Affiliated Hospitals (1972-75 and 1975-77 respectively). He is a diplomate of the American Board of Internal Medicine (1975) and the American Board of Dermatology (1977, 1999, and 2009).
In 1977 Dr. Callen joined the faculty at the University of Louisville. He became the Residency program director in 1984, a position that he held until July 1, 2016. He was promoted to the rank of Professor as well as being appointed as Chief of the Division of Dermatology in 1988, and still holds the position of Chief of the Division of Dermatology.
He has served on the Board of Directors of the Dermatology Foundation (1983-8), the American Academy of Dermatology (AAD) (1994-8), Association of Professors of Dermatology (1996-9), the American Board of Dermatology, Inc. (ABD) (2003-2011), the Medical Dermatology Society (2001-2005) and the American Dermatologic Association (2009-2013). He Chaired the AAD’s Council on Education (2003-7). He has been Vice-President of the AAD in 2004-5, President of the Medical Dermatology Society (2006-8), vice president of the ABD 2011 and was President of the Association of Professors of Dermatology (2016-2018). He is currently the President-elect of the American Dermatological Association (2019-2020). He serves on the Accreditation Council for Continuing Medical Education’s review committee (2017- current).
Locally, he has served on the boards of the Jewish Community Center, Jewish Family and Vocational Services, Actors Theatre of Louisville, the Kentucky Arts and Crafts Foundation, and the Speed Art Museum. He and his wife are currently heading the Cinephile Collector’s group for the Speed Art Museum.
He was the Associate Editor of the JAMA Dermatology from 2004-2018, and has remained on its editorial board (2018-current) and is Editor in Chief of the Dermatology Section of UpToDate.
He is an honorary member of the following organizations: Honorary Corresponding Member, Pacific Dermatologic Association, 1987; Honorary Fellow, North American Clinical Dermatologic Society, April 2007; Medical Dermatology Society, February 2011; Florida Society of Dermatology and Dermatologic Surgery – May 2012; and the American Academy of Dermatology, March 2013. He is a Master of Rheumatology (2016) and is the first dermatologist to receive this designation.
He has been listed in Best Doctors annually since 1992 and has received the American Academy of Dermatology Thomas Pearson, PhD Education Award. He was given the Medical Dermatology Society’s Lifetime Achievement award in 2011. He was selected by the American Academy of Dermatology to receive the 2017 Master Dermatologist Award. In 2018, the Dermatology Foundation selected him for their Lifetime Career Educator Award.
Recent Contributions to PracticeUpdate:
- Safety and Efficacy of Treatment With JAK Inhibitors in Patients With Scleroderma
- Epidemiology and Diagnostic Classification of Adults Presenting With an Initial Episode of Leukocytoclastic Vasculitis
- Anti-CCAR1 Autoantibodies Are Specific for Anti–TIF1-γ Antibody–Positive Dermatomyositis and Decrease Cancer Risk Relative to the General Population
- Cutaneous Lupus Erythematosus Responds to Both Methotrexate and Mycophenolate Mofetil
- The Effectiveness of Rituximab in Pemphigus and the Benefit of Additional Maintenance Infusions
- Malignancy in Dermatomyositis
- Occult Malignancies in Young Dermatomyositis Patients
- Antinuclear Antibody Status, Clinical Features, and Malignancy Risk in Adult-Onset Dermatomyositis